MedTrace Logo

Protective Effects of Dexmedetomidine on Myocardial Injury During Liver Transplantation

NCT03013634 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2017-01-06

No results posted yet for this study

Summary

The purpose of this study was to evaluate the protective effect of dexmedetomidine on myocardial injury during liver transplantation

Conditions

  • Evidence of Liver Transplantation
  • Myocardial Injury

Interventions

DRUG

Dexmedetomidine

Dexmedetomidine infusion:loading 0.5ug/kg for 10min, then 0.5 ug/kg/h until the end of operation.

DRUG

Normal saline

Equal volume normal saline substitute for dexmedetomidine

Sponsors & Collaborators

  • Tianjin First Central Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2017-10-31
Completion
2017-11-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03013634 on ClinicalTrials.gov